• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy
    Subscribe to $IRTC

    iRhythm Technologies Inc.

    Subscribe to $IRTC
    $IRTC
    Medical/Dental Instruments
    Health Care

    iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. The company's Zio XT and AT monitors, a single-use, wire-free, and wearable patch-based biosensors, records patient's heartbeats and ECG data. It has a development collaboration agreement with Verily Life Sciences LLC to develop various next-generation atrial fibrillation screening, detection, or monitoring products. iRhythm Technologies, Inc. was incorporated in 2006 and is headquartered in San Francisco, California.

    IPO Year: 2016

    Exchange: NASDAQ

    Website: irhythmtech.com

    Recent Analyst Ratings for iRhythm Technologies Inc.

    DatePrice TargetRatingAnalyst
    5/2/2025$130.00Equal Weight → Overweight
    Wells Fargo
    12/3/2024$86.00Equal Weight
    Wells Fargo
    10/4/2024$78.00Neutral
    Goldman
    6/20/2024$115.00Peer Perform → Outperform
    Wolfe Research
    12/11/2023$110.00Neutral → Buy
    Citigroup
    7/19/2023$130.00Outperform
    Robert W. Baird
    2/7/2023$150.00Overweight
    Wells Fargo
    11/7/2022Underperform → Peer Perform
    Wolfe Research
    6/9/2022$180.00 → $155.00Buy → Neutral
    Citigroup
    4/6/2022$105.00Underperform
    Wolfe Research
    See more ratings

    iRhythm Technologies Inc. Press Releases

    Fastest customizable press release news feed in the world

    See more
    • iRhythm Technologies to Participate in Upcoming Investor Conferences

      SAN FRANCISCO, May 21, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced that its management team is scheduled to present at the following investor conferences. William Blair 45th Annual Growth Stock Conference on Wednesday, June 4, 2025, at 2:00 p.m. Central Time (12:00 p.m. Pacific Time)Goldman Sachs 46th Annual Global Healthcare Conference on Tuesday, June 10, 2025, at 2:40 p.m. Eastern Time (11:40 a.m. Pacific Time)Truist Securities MedTech Conference on Tuesday, June 17, 2025, at 1:40 p.m. Eastern Time (10:40 a.m. Pacific Time) Inter

      5/21/25 4:45:00 PM ET
      $IRTC
      Medical/Dental Instruments
      Health Care
    • iRhythm Launches Zio® Long-Term Continuous Monitoring Service in Japan as the Zio® ECG Recording and Analysis System, Advancing AI-Powered Arrhythmia Detection

      iRhythm Zio® Long-Term Continuous Monitoring (LTCM) system — commercially introduced in Japan as the Zio® ECG Recording and Analysis System — brings AI-powered, continuous, uninterrupted ECG monitoring for up to 14 days to JapanLaunch is timely amid a growing demand for early, accurate detection of arrhythmias in Japan, the second largest ambulatory cardiac monitoring market in the world, where the prevalence is expected to rise alongside an aging population1-3 SAN FRANCISCO, May 01, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC) today announced the commercial launch in Japan of its Zio® long-term continuous ECG monitoring (LTCM) system, commercially introduced in thi

      5/1/25 4:10:00 PM ET
      $IRTC
      Medical/Dental Instruments
      Health Care
    • iRhythm Technologies Announces First Quarter 2025 Financial Results

      SAN FRANCISCO, May 01, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today reported financial results for the three months ended March 31, 2025. First Quarter 2025 Financial Highlights Revenue of $158.7 million, a 20.3% increase compared to first quarter 2024Gross margin of 68.8%, a 250-basis point increase compared to first quarter 2024Unrestricted cash, cash equivalents, and marketable securities of $520.6 million as of March 31, 2025Increased fiscal year 2025 guidance for revenue and adjusted EBITDA margin Recent Operational Highlights Strong qu

      5/1/25 4:05:00 PM ET
      $IRTC
      Medical/Dental Instruments
      Health Care
    • iRhythm Technologies to Present at the Bank of America Securities 2025 Health Care Conference

      SAN FRANCISCO, April 29, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced the company will be participating in the upcoming Bank of America Securities 2025 Health Care Conference. iRhythm's management is scheduled to present on Tuesday, May 13, 2025, 3:40 p.m. Pacific Time/6:40 p.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the "Events & Presentations" section of the company's investor website at investors.irhythmtech.com. About iRhythm Technologies, Inc. iRhythm is a leading digit

      4/29/25 6:05:00 PM ET
      $IRTC
      Medical/Dental Instruments
      Health Care
    • iRhythm Presents New Real-World Data on Ambulatory Cardiac Monitoring at HRS 2025 Reinforcing Clinical Superiority of Zio Long-Term Continuous Monitoring

      Findings in a younger, commercially insured population build on Medicare-based CAMELOT results, expanding the generalizability of Zio LTCM's clinical impact across patient groups.Latest data showed Zio LTCM was associated with higher diagnostic yield and lower likelihood of repeat testing and cardiovascular events compared to all other LTCM products. SAN FRANCISCO, April 28, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC) announced results from a large real-world retrospective analysis presented at the Heart Rhythm Society's annual meeting, HRS2025, held April 24–27 in San Diego, CA, The Assessment of Variation in AmbuLatory Cardiac MONitoring: Real-World Evidenc

      4/28/25 8:05:00 AM ET
      $IRTC
      Medical/Dental Instruments
      Health Care
    • iRhythm Technologies to Report First Quarter 2025 Financial Results on May 1, 2025

      SAN FRANCISCO, April 17, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced that it will release financial results for the first quarter 2025 after the close of trading on Thursday, May 1, 2025. The company's management team will host a corresponding conference call beginning at 1:30 p.m. PT / 4:30 p.m. ET. Interested parties may access a live and archived webcast of the conference call on the "Quarterly Results" section of the company's investor website at investors.irhythmtech.com. About iRhythm Technologies, Inc. iRhythm is a leading di

      4/17/25 4:30:00 PM ET
      $IRTC
      Medical/Dental Instruments
      Health Care
    • iRhythm Technologies Releases 2024 Corporate Sustainability Report That Demonstrates Ongoing Commitment to Culture of Quality and Sustainability

      SAN FRANCISCO, April 16, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today announced that it has published its 2024 Corporate Sustainability Report, highlighting the company's efforts to build a sustainable and inclusive future. "iRhythm's core mission is to create a better world for patients by delivering better health and better insights through our trusted solutions and innovative technologies," said Sumi Shrishrimal, iRhythm's Chief Risk Officer and leader of Sustainability and Impact. "We accomplish this by being a responsible, ethical, and i

      4/16/25 8:35:00 AM ET
      $IRTC
      Medical/Dental Instruments
      Health Care
    • Turing Medical Names Transformative Med Tech Leader Kevin King as President and Chief Executive Officer

      With three decades of spearheading advances in precision medicine and diagnostic technologies, King will accelerate the company's next phase of expansion. Turing Medical, a leader in precision brain mapping and targeting technologies, announced the appointment of Kevin King, former CEO of iRhythm Technologies, Affymetrix and Thomson Reuters Healthcare, as the company's new President and Chief Executive Officer (CEO). Turing Medical is developing advanced functional connectivity MRI processing techniques with the potential to generate highly detailed, personalized circuit maps that could help in the understanding and treatment of brain disorders. "Bringing Kevin King on as CEO marks a defi

      4/15/25 10:00:00 AM ET
      $IRTC
      Medical/Dental Instruments
      Health Care
    • iRhythm Unveils New Real-World Data at ACC.25 Demonstrating the Benefits of Zio® Long-Term Continuous Monitoring for Arrhythmia Detection

      SAN FRANCISCO, March 31, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC) today announced results from two large real-world retrospective analyses presented at the American College of Cardiology (ACC) 2025 Scientific Sessions in Chicago, IL. Drawing on data from more than 1.1 million patients who used iRhythm's Zio® long-term continuous monitoring (LTCM) ECG devices, these studies demonstrate that short-term (24–48-hour) monitoring, such as with Holter devices, fails to detect a significant proportion of actionable arrhythmias—even in patients reporting "daily symptoms"—and that Symptom–Rhythm Correlation (SRC) is notably low for most arrhythmias, underscoring that selecti

      3/31/25 8:05:00 AM ET
      $IRTC
      Medical/Dental Instruments
      Health Care
    • iRhythm Technologies Announces Fourth Quarter and Full Year 2024 Financial Results

      SAN FRANCISCO, Feb. 20, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today reported financial results for the three months and full year ended December 31, 2024. Fourth Quarter 2024 Financial Highlights Revenue of $164.3 million, a 24.0% increase compared to fourth quarter 2023Gross margin of 70.0%, a 410-basis point increase compared to fourth quarter 2023Net loss of $1.3 million, a $37.4 million improvement compared to fourth quarter 2023Adjusted EBITDA of $19.3 million, a $16.9 million improvement compared to fourth quarter 2023Cash, cash equ

      2/20/25 4:05:00 PM ET
      $IRTC
      Medical/Dental Instruments
      Health Care

    iRhythm Technologies Inc. Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • iRhythm upgraded by Wells Fargo with a new price target

      Wells Fargo upgraded iRhythm from Equal Weight to Overweight and set a new price target of $130.00

      5/2/25 8:03:46 AM ET
      $IRTC
      Medical/Dental Instruments
      Health Care
    • Wells Fargo resumed coverage on iRhythm with a new price target

      Wells Fargo resumed coverage of iRhythm with a rating of Equal Weight and set a new price target of $86.00

      12/3/24 7:33:58 AM ET
      $IRTC
      Medical/Dental Instruments
      Health Care
    • Goldman initiated coverage on iRhythm with a new price target

      Goldman initiated coverage of iRhythm with a rating of Neutral and set a new price target of $78.00

      10/4/24 7:40:56 AM ET
      $IRTC
      Medical/Dental Instruments
      Health Care
    • iRhythm upgraded by Wolfe Research with a new price target

      Wolfe Research upgraded iRhythm from Peer Perform to Outperform and set a new price target of $115.00

      6/20/24 7:35:11 AM ET
      $IRTC
      Medical/Dental Instruments
      Health Care
    • iRhythm upgraded by Citigroup with a new price target

      Citigroup upgraded iRhythm from Neutral to Buy and set a new price target of $110.00

      12/11/23 8:11:00 AM ET
      $IRTC
      Medical/Dental Instruments
      Health Care
    • Robert W. Baird initiated coverage on iRhythm with a new price target

      Robert W. Baird initiated coverage of iRhythm with a rating of Outperform and set a new price target of $130.00

      7/19/23 7:16:55 AM ET
      $IRTC
      Medical/Dental Instruments
      Health Care
    • Wells Fargo initiated coverage on iRhythm with a new price target

      Wells Fargo initiated coverage of iRhythm with a rating of Overweight and set a new price target of $150.00

      2/7/23 8:49:15 AM ET
      $IRTC
      Medical/Dental Instruments
      Health Care
    • iRhythm upgraded by Wolfe Research

      Wolfe Research upgraded iRhythm from Underperform to Peer Perform

      11/7/22 7:31:08 AM ET
      $IRTC
      Medical/Dental Instruments
      Health Care
    • iRhythm downgraded by Citigroup with a new price target

      Citigroup downgraded iRhythm from Buy to Neutral and set a new price target of $155.00 from $180.00 previously

      6/9/22 7:17:13 AM ET
      $IRTC
      Medical/Dental Instruments
      Health Care
    • Wolfe Research initiated coverage on iRhythm with a new price target

      Wolfe Research initiated coverage of iRhythm with a rating of Underperform and set a new price target of $105.00

      4/6/22 7:22:16 AM ET
      $IRTC
      Medical/Dental Instruments
      Health Care

    iRhythm Technologies Inc. SEC Filings

    See more
    • iRhythm Technologies Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

      8-K - iRhythm Technologies, Inc. (0001388658) (Filer)

      5/30/25 4:01:53 PM ET
      $IRTC
      Medical/Dental Instruments
      Health Care
    • SEC Form SD filed by iRhythm Technologies Inc.

      SD - iRhythm Technologies, Inc. (0001388658) (Filer)

      5/21/25 4:02:02 PM ET
      $IRTC
      Medical/Dental Instruments
      Health Care
    • Amendment: SEC Form SCHEDULE 13G/A filed by iRhythm Technologies Inc.

      SCHEDULE 13G/A - iRhythm Technologies, Inc. (0001388658) (Subject)

      5/13/25 11:32:29 AM ET
      $IRTC
      Medical/Dental Instruments
      Health Care
    • SEC Form 10-Q filed by iRhythm Technologies Inc.

      10-Q - iRhythm Technologies, Inc. (0001388658) (Filer)

      5/1/25 5:21:22 PM ET
      $IRTC
      Medical/Dental Instruments
      Health Care
    • iRhythm Technologies Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - iRhythm Technologies, Inc. (0001388658) (Filer)

      5/1/25 4:10:23 PM ET
      $IRTC
      Medical/Dental Instruments
      Health Care
    • SEC Form DEFA14A filed by iRhythm Technologies Inc.

      DEFA14A - iRhythm Technologies, Inc. (0001388658) (Filer)

      4/16/25 7:25:03 AM ET
      $IRTC
      Medical/Dental Instruments
      Health Care
    • SEC Form DEF 14A filed by iRhythm Technologies Inc.

      DEF 14A - iRhythm Technologies, Inc. (0001388658) (Filer)

      4/16/25 7:19:37 AM ET
      $IRTC
      Medical/Dental Instruments
      Health Care
    • SEC Form 10-K filed by iRhythm Technologies Inc.

      10-K - iRhythm Technologies, Inc. (0001388658) (Filer)

      2/20/25 5:21:12 PM ET
      $IRTC
      Medical/Dental Instruments
      Health Care
    • iRhythm Technologies Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - iRhythm Technologies, Inc. (0001388658) (Filer)

      2/20/25 4:09:26 PM ET
      $IRTC
      Medical/Dental Instruments
      Health Care
    • iRhythm Technologies Inc. filed SEC Form 8-K: Leadership Update

      8-K - iRhythm Technologies, Inc. (0001388658) (Filer)

      1/27/25 4:48:50 PM ET
      $IRTC
      Medical/Dental Instruments
      Health Care

    iRhythm Technologies Inc. Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Yoor Brian B was granted 1,358 shares, increasing direct ownership by 32% to 5,598 units (SEC Form 4)

      4 - iRhythm Technologies, Inc. (0001388658) (Issuer)

      5/29/25 4:06:28 PM ET
      $IRTC
      Medical/Dental Instruments
      Health Care
    • Director Snyderman Ralph was granted 1,358 shares, increasing direct ownership by 11% to 13,288 units (SEC Form 4)

      4 - iRhythm Technologies, Inc. (0001388658) (Issuer)

      5/29/25 4:04:54 PM ET
      $IRTC
      Medical/Dental Instruments
      Health Care
    • Director Bodaken Bruce G. was granted 1,358 shares, increasing direct ownership by 12% to 12,638 units (SEC Form 4)

      4 - iRhythm Technologies, Inc. (0001388658) (Issuer)

      5/29/25 4:05:39 PM ET
      $IRTC
      Medical/Dental Instruments
      Health Care
    • Director Bairey Merz Cathleen Noel was granted 1,358 shares, increasing direct ownership by 18% to 8,973 units (SEC Form 4)

      4 - iRhythm Technologies, Inc. (0001388658) (Issuer)

      5/29/25 4:04:06 PM ET
      $IRTC
      Medical/Dental Instruments
      Health Care
    • Director Talwalkar Abhijit Y was granted 1,358 shares, increasing direct ownership by 7% to 20,299 units (SEC Form 4)

      4 - iRhythm Technologies, Inc. (0001388658) (Issuer)

      5/29/25 4:03:30 PM ET
      $IRTC
      Medical/Dental Instruments
      Health Care
    • Director Ling Karen was granted 1,358 shares, increasing direct ownership by 17% to 9,568 units (SEC Form 4)

      4 - iRhythm Technologies, Inc. (0001388658) (Issuer)

      5/29/25 4:02:44 PM ET
      $IRTC
      Medical/Dental Instruments
      Health Care
    • Director Rubash Mark J was granted 1,358 shares, increasing direct ownership by 11% to 13,788 units (SEC Form 4)

      4 - iRhythm Technologies, Inc. (0001388658) (Issuer)

      5/29/25 4:01:57 PM ET
      $IRTC
      Medical/Dental Instruments
      Health Care
    • Chief Technology Officer Lawrence Brian Lee was granted 14,479 shares (SEC Form 4)

      4 - iRhythm Technologies, Inc. (0001388658) (Issuer)

      5/6/25 6:06:55 PM ET
      $IRTC
      Medical/Dental Instruments
      Health Care
    • Chief Financial Officer Wilson Daniel G. sold $250,000 worth of shares (2,000 units at $125.00), decreasing direct ownership by 4% to 43,307 units (SEC Form 4)

      4 - iRhythm Technologies, Inc. (0001388658) (Issuer)

      5/5/25 4:11:18 PM ET
      $IRTC
      Medical/Dental Instruments
      Health Care
    • Chief Commercial Officer Patterson Chad sold $1,025,898 worth of shares (8,510 units at $120.55), decreasing direct ownership by 15% to 49,930 units (SEC Form 4)

      4 - iRhythm Technologies, Inc. (0001388658) (Issuer)

      5/5/25 4:10:38 PM ET
      $IRTC
      Medical/Dental Instruments
      Health Care

    iRhythm Technologies Inc. Financials

    Live finance-specific insights

    See more
    • iRhythm Technologies Announces First Quarter 2025 Financial Results

      SAN FRANCISCO, May 01, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today reported financial results for the three months ended March 31, 2025. First Quarter 2025 Financial Highlights Revenue of $158.7 million, a 20.3% increase compared to first quarter 2024Gross margin of 68.8%, a 250-basis point increase compared to first quarter 2024Unrestricted cash, cash equivalents, and marketable securities of $520.6 million as of March 31, 2025Increased fiscal year 2025 guidance for revenue and adjusted EBITDA margin Recent Operational Highlights Strong qu

      5/1/25 4:05:00 PM ET
      $IRTC
      Medical/Dental Instruments
      Health Care
    • iRhythm Technologies to Report First Quarter 2025 Financial Results on May 1, 2025

      SAN FRANCISCO, April 17, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced that it will release financial results for the first quarter 2025 after the close of trading on Thursday, May 1, 2025. The company's management team will host a corresponding conference call beginning at 1:30 p.m. PT / 4:30 p.m. ET. Interested parties may access a live and archived webcast of the conference call on the "Quarterly Results" section of the company's investor website at investors.irhythmtech.com. About iRhythm Technologies, Inc. iRhythm is a leading di

      4/17/25 4:30:00 PM ET
      $IRTC
      Medical/Dental Instruments
      Health Care
    • iRhythm Technologies Announces Fourth Quarter and Full Year 2024 Financial Results

      SAN FRANCISCO, Feb. 20, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today reported financial results for the three months and full year ended December 31, 2024. Fourth Quarter 2024 Financial Highlights Revenue of $164.3 million, a 24.0% increase compared to fourth quarter 2023Gross margin of 70.0%, a 410-basis point increase compared to fourth quarter 2023Net loss of $1.3 million, a $37.4 million improvement compared to fourth quarter 2023Adjusted EBITDA of $19.3 million, a $16.9 million improvement compared to fourth quarter 2023Cash, cash equ

      2/20/25 4:05:00 PM ET
      $IRTC
      Medical/Dental Instruments
      Health Care
    • iRhythm Technologies to Report Fourth Quarter and Full Year 2024 Financial Results on February 20, 2025

      SAN FRANCISCO, Feb. 06, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced that it will release financial results for the fourth quarter and full year 2024 after the close of trading on Thursday, February 20, 2025. The company's management team will host a corresponding conference call beginning at 1:30 p.m. PT / 4:30 p.m. ET. Interested parties may access a live and archived webcast of the conference call on the "Quarterly Results" section of the company's investor website at investors.irhythmtech.com. About iRhythm Technologies, Inc. iRh

      2/6/25 4:05:00 PM ET
      $IRTC
      Medical/Dental Instruments
      Health Care
    • iRhythm Technologies Announces Third Quarter 2024 Financial Results

      SAN FRANCISCO, Oct. 30, 2024 (GLOBE NEWSWIRE) --  iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today reported financial results for the three months ended September 30, 2024. Third Quarter 2024 Financial Highlights Revenue of $147.5 million, an 18% increase compared to third quarter 2023Gross margin of 68.8%, a 260-basis point increase compared to third quarter 2023Unrestricted cash, cash equivalents and marketable securities of $522.0 million as of September 30, 2024 Recent Operational Highlights Strong quarterly registration volume driven by record demand from existing

      10/30/24 4:08:07 PM ET
      $IRTC
      Medical/Dental Instruments
      Health Care
    • iRhythm Technologies to Report Third Quarter 2024 Financial Results on October 30, 2024

      SAN FRANCISCO, Oct. 16, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced that it will release financial results for the third quarter 2024 after the close of trading on Wednesday, October 30, 2024. The company's management team will host a corresponding conference call beginning at 1:30 p.m. PT / 4:30 p.m. ET. Interested parties may access a live and archived webcast of the presentation on the "Events & Presentations" section of the company's investor website at investors.irhythmtech.com. About iRhythm Technologies, Inc. iRhythm is a lea

      10/16/24 4:05:00 PM ET
      $IRTC
      Medical/Dental Instruments
      Health Care
    • iRhythm Technologies Announces Second Quarter 2024 Financial Results

      SAN FRANCISCO, Aug. 01, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today reported financial results for the three months ended June 30, 2024. Second Quarter 2024 Financial Highlights Revenue of $148.0 million, a 19.3% increase compared to second quarter 2023Gross margin of 69.9%, a 40-basis point increase compared to second quarter 2023Unrestricted cash, cash equivalents and marketable securities of $561.5 million as of June 30, 2024Increased fiscal year 2024 guidance for revenue, gross margin, and adjusted EBITDA Recent Operational Highlights R

      8/1/24 4:05:00 PM ET
      $IRTC
      Medical/Dental Instruments
      Health Care
    • iRhythm Technologies to Report Second Quarter 2024 Financial Results on August 1, 2024

      SAN FRANCISCO, July 18, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced that it will release financial results for the second quarter 2024 after the close of trading on Thursday, August 1, 2024. The company's management team will host a corresponding conference call beginning at 1:30 p.m. PT / 4:30 p.m. ET. Interested parties may access a live and archived webcast of the presentation on the "Events & Presentations" section of the company's investor website at investors.irhythmtech.com. About iRhythm Technologies, Inc. iRhythm is a leadi

      7/18/24 4:05:00 PM ET
      $IRTC
      Medical/Dental Instruments
      Health Care
    • iRhythm Technologies Announces First Quarter 2024 Financial Results

      SAN FRANCISCO, May 02, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today reported financial results for the three months ended March 31, 2024. First Quarter 2024 Financial Highlights Revenue of $131.9 million, a 18.4% increase compared to first quarter 2023Gross margin of 66.3%, a 160-basis point decline compared to first quarter 2023Unrestricted cash, cash equivalents and marketable securities of $569.1 million as of March 31, 2024Increased fiscal year 2024 revenue guidance to a range of $578 million to $588 million Recent Opera

      5/2/24 4:05:00 PM ET
      $IRTC
      Medical/Dental Instruments
      Health Care
    • iRhythm Technologies to Report First Quarter 2024 Financial Results on May 2, 2024

      SAN FRANCISCO, April 18, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced that it will release financial results for the first quarter 2024 after the close of trading on Thursday, May 2, 2024. The company's management team will host a corresponding conference call beginning at 1:30 p.m. PT / 4:30 p.m. ET. Interested parties may access a live and archived webcast of the presentation on the "Events & Presentations" section of the company's investor website at investors.irhythmtech.com. About iRhythm Technologies, Inc. iRhythm is a leading

      4/18/24 4:05:00 PM ET
      $IRTC
      Medical/Dental Instruments
      Health Care

    iRhythm Technologies Inc. Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by iRhythm Technologies Inc.

      SC 13G/A - iRhythm Technologies, Inc. (0001388658) (Subject)

      11/12/24 12:54:21 PM ET
      $IRTC
      Medical/Dental Instruments
      Health Care
    • Amendment: SEC Form SC 13G/A filed by iRhythm Technologies Inc.

      SC 13G/A - iRhythm Technologies, Inc. (0001388658) (Subject)

      11/12/24 9:52:49 AM ET
      $IRTC
      Medical/Dental Instruments
      Health Care
    • Amendment: SEC Form SC 13G/A filed by iRhythm Technologies Inc.

      SC 13G/A - iRhythm Technologies, Inc. (0001388658) (Subject)

      11/7/24 4:05:49 PM ET
      $IRTC
      Medical/Dental Instruments
      Health Care
    • SEC Form SC 13G/A filed by iRhythm Technologies Inc. (Amendment)

      SC 13G/A - iRhythm Technologies, Inc. (0001388658) (Subject)

      2/13/24 3:45:44 PM ET
      $IRTC
      Medical/Dental Instruments
      Health Care
    • SEC Form SC 13G filed by iRhythm Technologies Inc.

      SC 13G - iRhythm Technologies, Inc. (0001388658) (Subject)

      2/12/24 6:27:56 AM ET
      $IRTC
      Medical/Dental Instruments
      Health Care
    • SEC Form SC 13G filed by iRhythm Technologies Inc.

      SC 13G - iRhythm Technologies, Inc. (0001388658) (Subject)

      2/9/24 5:49:06 PM ET
      $IRTC
      Medical/Dental Instruments
      Health Care
    • SEC Form SC 13G/A filed by iRhythm Technologies Inc. (Amendment)

      SC 13G/A - iRhythm Technologies, Inc. (0001388658) (Subject)

      1/25/24 4:59:27 PM ET
      $IRTC
      Medical/Dental Instruments
      Health Care
    • SEC Form SC 13G/A filed by iRhythm Technologies Inc. (Amendment)

      SC 13G/A - iRhythm Technologies, Inc. (0001388658) (Subject)

      2/14/23 3:22:57 PM ET
      $IRTC
      Medical/Dental Instruments
      Health Care
    • SEC Form SC 13G/A filed by iRhythm Technologies Inc. (Amendment)

      SC 13G/A - iRhythm Technologies, Inc. (0001388658) (Subject)

      2/9/23 11:22:23 AM ET
      $IRTC
      Medical/Dental Instruments
      Health Care
    • SEC Form SC 13G/A filed by iRhythm Technologies Inc. (Amendment)

      SC 13G/A - iRhythm Technologies, Inc. (0001388658) (Subject)

      1/31/23 1:58:05 PM ET
      $IRTC
      Medical/Dental Instruments
      Health Care

    iRhythm Technologies Inc. Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Talwalkar Abhijit Y bought $500,866 worth of shares (6,664 units at $75.16), increasing direct ownership by 54% to 18,941 units (SEC Form 4)

      4 - iRhythm Technologies, Inc. (0001388658) (Issuer)

      11/5/24 11:59:44 AM ET
      $IRTC
      Medical/Dental Instruments
      Health Care
    • Chief Commercial Officer Patterson Chad bought $20,994 worth of shares (280 units at $74.98) and sold $224,876 worth of shares (3,012 units at $74.66), decreasing direct ownership by 7% to 37,133 units (SEC Form 4)

      4 - iRhythm Technologies, Inc. (0001388658) (Issuer)

      8/5/24 5:35:18 PM ET
      $IRTC
      Medical/Dental Instruments
      Health Care
    • Blackford Quentin S. bought $997,644 worth of shares (9,755 units at $102.27), increasing direct ownership by 8% to 128,510 units (SEC Form 4) (Amendment)

      4/A - iRhythm Technologies, Inc. (0001388658) (Issuer)

      12/6/23 7:08:38 PM ET
      $IRTC
      Medical/Dental Instruments
      Health Care

    iRhythm Technologies Inc. Leadership Updates

    Live Leadership Updates

    See more
    • iRhythm collaborates with Epic to streamline access to Zio® service and drive more seamless connectivity between clinicians and patients

      iRhythm is the first medical device company to join the Epic community, using Aura to drive efficiencies through EHR integrationThe collaboration will expand access to Zio service across the continuum of patient care—from cardiology to primary care to emergency departments and beyond1 SAN FRANCISCO, Feb. 29, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital healthcare company focused on creating trusted solutions that detect, predict, and prevent disease, today announced it will use Epic's Aura platform to streamline access to iRhythm's Zio long-term continuous monitoring and ambulatory mobile cardiac telemetry services ("Zio services") through improved

      2/29/24 4:30:00 PM ET
      $IRTC
      Medical/Dental Instruments
      Health Care
    • Derrick Sung Joins Aerin Medical as Chief Financial Officer

      A seasoned leader, Sung brings deep finance, capital markets, and strategy experience across the medical device industry Aerin Medical Inc., a company dedicated to providing Ear, Nose and Throat (ENT) physicians with non-invasive solutions for the treatment of chronic nasal conditions, announced today that Derrick Sung has been appointed chief financial officer of the company. Sung brings over 25 years of finance, capital markets, and strategy experience across diverse roles within the medical device industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20231120576987/en/Derrick Sung has been appointed chief financial officer

      11/20/23 9:00:00 AM ET
      $IRTC
      $LUNG
      Medical/Dental Instruments
      Health Care
    • iRhythm Technologies Further Strengthens its Board of Directors with Two New Independent Director Appointments

      SAN FRANCISCO, June 06, 2023 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today announced the appointment of Mojdeh Poul and Brian Yoor as directors to its Board effective June 1, 2023. "On behalf of the entire iRhythm team, I am thrilled to welcome Mojdeh and Brian to our Board of Directors," said Quentin Blackford, iRhythm's President and CEO. "Both bring extensive operational experience, strong financial acumen, and public company leadership across the global healthcare and medical technology sectors. We believe their proven track record of delivering

      6/6/23 9:00:39 AM ET
      $IRTC
      Medical/Dental Instruments
      Health Care
    • iRhythm Technologies Announces the Addition of Two Executive Leaders to Advance Strategic Growth and Operational Excellence

      SAN FRANCISCO, July 25, 2022 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital healthcare solutions company focused on the advancement of cardiac care, today announced the appointment of two seasoned executives to its leadership team. Brice Bobzien will join the company as the Chief Financial Officer on August 8, 2022, to lead all financial operations of the company as well as to advance the culture of operational excellence and prepare the company for future growth. Reyna Fernandez will join as the company's Executive Vice President, Chief Human Resources Officer on July 25, 2022, to lead the development and implementation of human resources strategies in sup

      7/25/22 4:15:00 PM ET
      $IRTC
      Medical/Dental Instruments
      Health Care
    • iRhythm® Technologies Announces Changes to Its Board of Directors

      SAN FRANCISCO, Oct. 12, 2021 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC) ("iRhythm"), a leading digital healthcare solutions company focused on the advancement of cardiac care, today announced the appointment of Karen Ling, an experienced HR leader, to its Board of Directors effective November 1, 2021. Ms. Ling was appointed as a Class 1 Director. The company also announced the retirement of Raymond Scott from the Board, effective November 1, 2021. Mr. Scott joined the iRhythm Board in 2013. "On behalf of the entire iRhythm team, I am pleased to welcome Karen to our Board of Directors," said Quentin Blackford, iRhythm President and CEO. "Karen is a renowned HR leader in t

      10/12/21 4:05:00 PM ET
      $IRTC
      Medical/Dental Instruments
      Health Care
    • iRhythm Technologies President and CEO Kevin King to Retire; Michael Coyle Joins Company as President and CEO Effective January 12, 2021

      SAN FRANCISCO, Dec. 14, 2020 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, today announced that Kevin King will retire as President and CEO effective January 12, 2021. Mr. King will continue to serve on iRhythm's board of directors and as an advisor to the business. Effective the same date, Mike Coyle will join the company as President and CEO and as a member of its board of directors. Under King’s leadership, iRhythm successfully completed an IPO in 2016, achieved record financial growth and increased shareholder value significantly. During his tenure, the company’s annual revenue

      12/14/20 4:40:00 PM ET
      $IRTC
      Medical/Dental Instruments
      Health Care